Drug Profile
AF 102
Alternative Names: AF102Latest Information Update: 23 Jan 2019
Price :
$50
*
At a glance
- Originator PUMC Pharmaceutical Company
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Fissure in ano
Most Recent Events
- 23 Jan 2019 No recent reports of development identified after preregistration for Fissure in ano in China (unspecified route)
- 06 Jan 2016 Preregistration for Fissure in ano in China (unspecified route) before January 2016